These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29280318)

  • 21. Cultured corneal epithelia for ocular surface disease.
    Schwab IR
    Trans Am Ophthalmol Soc; 1999; 97():891-986. PubMed ID: 10703147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral partial limbal stem cell deficiency: contralateral versus ipsilateral autologous cultivated limbal epithelial transplantation.
    Vazirani J; Basu S; Kenia H; Ali MH; Kacham S; Mariappan I; Sangwan V
    Am J Ophthalmol; 2014 Mar; 157(3):584-90.e1-2. PubMed ID: 24269851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of autologous cultivated corneal epithelium for corneal limbal stem cell insufficiency--short-term results.
    Dobrowolski D; Wylegala E; Orzechowska-Wylegala B; Wowra B; Wróblewska-Czajka E
    Klin Oczna; 2011; 113(10-12):346-51. PubMed ID: 22384653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Current State of Advanced Therapy Medicinal Products in the Czech Republic.
    Kočí Z; Boráň T; Krůpa P; Kubinová Š
    Hum Gene Ther Clin Dev; 2018 Sep; 29(3):132-147. PubMed ID: 29869533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Safety monitoring of cell-based medicinal products (CBMPs)].
    Funk MB; Frech M; Spranger R; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1239-46. PubMed ID: 26391098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety outcomes and long-term effectiveness of ex vivo autologous cultured limbal epithelial transplantation for limbal stem cell deficiency.
    Fasolo A; Pedrotti E; Passilongo M; Marchini G; Monterosso C; Zampini R; Bohm E; Birattari F; Franch A; Barbaro V; Bertolin M; Breda C; Di Iorio E; Ferrari B; Ferrari S; Meneguzzi M; Ponzin D
    Br J Ophthalmol; 2017 May; 101(5):640-649. PubMed ID: 27543289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [European Marketing Authorisation: a long process. Experiences of small biotech companies with the ATMP regulation].
    Buljovčić Z
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):831-8. PubMed ID: 21698536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization, isolation, expansion and clinical therapy of human corneal epithelial stem/progenitor cells.
    Li DQ; Wang Z; Yoon KC; Bian F
    J Stem Cells; 2014; 9(2):79-91. PubMed ID: 25158157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful primary culture and autologous transplantation of corneal limbal epithelial cells from minimal biopsy for unilateral severe ocular surface disease.
    Nakamura T; Inatomi T; Sotozono C; Koizumi N; Kinoshita S
    Acta Ophthalmol Scand; 2004 Aug; 82(4):468-71. PubMed ID: 15291944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EU marketing authorization review of orphan and non-orphan drugs does not differ.
    Putzeist M; Mantel-Teeuwisse AK; Llinares J; Gispen-De Wied CC; Hoes AW; Leufkens HG
    Drug Discov Today; 2013 Oct; 18(19-20):1001-6. PubMed ID: 23835230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple Limbal Epithelial Transplantation: Long-Term Clinical Outcomes in 125 Cases of Unilateral Chronic Ocular Surface Burns.
    Basu S; Sureka SP; Shanbhag SS; Kethiri AR; Singh V; Sangwan VS
    Ophthalmology; 2016 May; 123(5):1000-10. PubMed ID: 26896125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European regulation for therapeutic use of stem cells.
    Ferry N
    Biomed Mater Eng; 2017; 28(s1):S3-S7. PubMed ID: 28372273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe.
    Fregonese L; Greene L; Hofer M; Magrelli A; Naumann-Winter F; Larsson K; Sheean M; Stoyanova-Beninska V; Tsigkos S; Westermark K; Sepodes B
    Drug Discov Today; 2018 Jan; 23(1):90-100. PubMed ID: 29024805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical transplantation of ex vivo expanded autologous limbal epithelial cells using a culture medium with human serum as single supplement: a retrospective case series.
    Pathak M; Cholidis S; Haug K; Shahdadfar A; Moe MC; Nicolaissen B; Drolsum L
    Acta Ophthalmol; 2013 Dec; 91(8):769-75. PubMed ID: 22937779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular surface reconstruction using autologous rabbit oral mucosal epithelial sheets fabricated ex vivo on a temperature-responsive culture surface.
    Hayashida Y; Nishida K; Yamato M; Watanabe K; Maeda N; Watanabe H; Kikuchi A; Okano T; Tano Y
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1632-9. PubMed ID: 15851562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo expansion of corneal limbal epithelial/stem cells for corneal surface reconstruction.
    Ramaesh K; Dhillon B
    Eur J Ophthalmol; 2003 Jul; 13(6):515-24. PubMed ID: 12948308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of penetrating keratoplasty after autologous cultivated limbal epithelial transplantation for ocular surface burns.
    Basu S; Mohamed A; Chaurasia S; Sejpal K; Vemuganti GK; Sangwan VS
    Am J Ophthalmol; 2011 Dec; 152(6):917-924.e1. PubMed ID: 21851920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Procedure for the marketing authorization of an antibacterial agent].
    López Navas A; García-Escribano Ráez N; Flores Juberías Á; Suárez Gea ML
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):529-32. PubMed ID: 25124488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.